Luke Bamber

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

Paul W. Armstrong, Carolyn S.P. Lam, Kevin J. Anstrom et al. · JAMA · 2020 · 261 citations · Full text

Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer

Alexander Cohen, Luke Bamber, Stephan Rietbrock et al. · Thrombosis and Haemostasis · 2014 · 195 citations

The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients

Stefan Cano, Donna L. Lamping, Luke Bamber et al. · Health and Quality of Life Outcomes · 2012 · 108 citations · Full text

Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism

Bonno van Bellen, Luke Bamber, Francine Correa de Carvalho et al. · Current Medical Research and Opinion · 2014 · 105 citations

Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results

Christoph Gerlinger, Luke Bamber, Friedhelm Leverkus et al. · BMC Research Notes · 2019 · 101 citations · Full text